AU2003241629A1 - An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport - Google Patents
An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transportInfo
- Publication number
- AU2003241629A1 AU2003241629A1 AU2003241629A AU2003241629A AU2003241629A1 AU 2003241629 A1 AU2003241629 A1 AU 2003241629A1 AU 2003241629 A AU2003241629 A AU 2003241629A AU 2003241629 A AU2003241629 A AU 2003241629A AU 2003241629 A1 AU2003241629 A1 AU 2003241629A1
- Authority
- AU
- Australia
- Prior art keywords
- ileum
- administering
- bile acid
- inhibitor compound
- oral formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003405 Ileum Anatomy 0.000 title 1
- 239000003613 bile acid Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003241629A AU2003241629B2 (en) | 1999-04-19 | 2003-08-27 | An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9901387 | 1999-04-19 | ||
| AU46335/00A AU767425B2 (en) | 1999-04-19 | 2000-04-19 | An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport |
| AU2003241629A AU2003241629B2 (en) | 1999-04-19 | 2003-08-27 | An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU46335/00A Division AU767425B2 (en) | 1999-04-19 | 2000-04-19 | An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003241629A1 true AU2003241629A1 (en) | 2003-09-18 |
| AU2003241629B2 AU2003241629B2 (en) | 2005-06-16 |
Family
ID=39273524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003241629A Ceased AU2003241629B2 (en) | 1999-04-19 | 2003-08-27 | An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2003241629B2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL108633A (en) * | 1993-02-15 | 1998-07-15 | Wellcome Found | Hypolipidaemic benzothiazepine derivatives their preparation and pharmaceutical compositions containing them |
| RU2247579C2 (en) * | 1997-03-11 | 2005-03-10 | Джи. Ди. Сирл Энд Ко. | Combined treatment using benzothiepins inhibiting transport of bile acid in jejunum and inhibitors of hmg-coa-reductase |
-
2003
- 2003-08-27 AU AU2003241629A patent/AU2003241629B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0200793A3 (en) | An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport | |
| MXPA03003417A (en) | Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor. | |
| AU6900200A (en) | System for fabrication of indirect dental restoratives | |
| AU1928501A (en) | Formulations for pharmaceutical agents ionizable as free acids or free bases | |
| AU4996300A (en) | Method of electroporation-enhanced delivery of active agents | |
| IL141030A0 (en) | Hydroxy pipecolate hydromaxy acid derivatives as mmp inhibitors | |
| AU3192700A (en) | Medicinal compositions | |
| AU2001244611A1 (en) | Preparations for preventing bile acid diarrhea | |
| AU2006699A (en) | Phosphinic alkanoic acid derivatives | |
| EP1219659A4 (en) | Amphipathic compound having dendritic structure | |
| AU1530001A (en) | Inhibitor compositions | |
| HK1054038A1 (en) | Substituted n-benzyl-indol-3-yl gloyoxylic acid derivatives having an antitumural effect | |
| AU2575201A (en) | Use of hsp27 as an anti-inflammatory agent | |
| AU2773597A (en) | Pharmaceutical compositions for the sustained release of insoluble active principles | |
| HUP0103788A3 (en) | Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives | |
| AU3344399A (en) | Remedies for primary biliary cirrhosis | |
| AU1303201A (en) | Alkoxyiminoalkanoic acid derivatives | |
| AU1732401A (en) | Medicinal compositions for oral use | |
| AU3196200A (en) | Beta-amino acid derivatives | |
| AU2003241629A1 (en) | An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport | |
| AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
| AU7958000A (en) | Process for the preparation of oxyiminoalkanoic acid derivatives | |
| AU2002219191A1 (en) | Diaminodicarboxylic acid: peptide-based gemini surfactant compounds used for drug delivery | |
| AU7608100A (en) | 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors | |
| AU1608499A (en) | Zwitterionic fatty acid compounds for anti-inflamation |